Literature DB >> 16473099

Hypertensive emergency and severe hypertension: what to treat, who to treat, and how to treat.

John S Flanigan1, David Vitberg.   

Abstract

Remember to treat patients, not numbers. Use fast acting shortterm medicines only when convincing evidence of rapidly evolving end-organ damage is present. For all patients, emergent or asymptomatic, the treatment goal is long-term control of hypertension. Potent IV agents for the im-mediate control of elevated blood pressure need to be used cautiously,bearing in mind both the side effects and the hazards of overly rapid control of hypertension. Conventional oral medication regimens demonstrated to modify the risks of chronic hypertension should be used whenever possible and as early as is practical to promote gradual control of hypertension. Whenever a patient presents for the evaluation of severe hypertension in an emergent setting, take the opportunity to encourage appropriate ongoing follow-up; after all, hypertension is not a single episode, it is an ongoing threat to good health.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473099     DOI: 10.1016/j.mcna.2005.11.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Hypertensive emergencies in children.

Authors:  Pankaj Hari; Aditi Sinha
Journal:  Indian J Pediatr       Date:  2011-01-27       Impact factor: 1.967

Review 2.  Advances in management of acute hypertension: a concise review.

Authors:  David B Tulman; Stanislaw P A Stawicki; Thomas J Papadimos; Claire V Murphy; Sergio D Bergese
Journal:  Discov Med       Date:  2012-05       Impact factor: 2.970

3.  Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.

Authors:  Michelle F Gaynor; Garth C Wright; Sheryl Vondracek
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01

Review 4.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

5.  Incidence, aetiology and mortality secondary to hypertensive emergencies in a large-scale referral centre in Israel (1991-2010).

Authors:  A Leiba; O Cohen-Arazi; L Mendel; E J Holtzman; E Grossman
Journal:  J Hum Hypertens       Date:  2015-12-17       Impact factor: 3.012

6.  Hypertensive crisis caused by electrocauterization of the adrenal gland during hepatectomy.

Authors:  A Ram Doo; Ji-Seon Son; Young-Jin Han; Hee Chul Yu; Seonghoon Ko
Journal:  BMC Surg       Date:  2015-02-14       Impact factor: 2.102

Review 7.  Emerging insights in the first-step use of antihypertensive combination therapy.

Authors:  Keith Norris; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

8.  Perioperative acute hypertension-role of Clevidipine butyrate.

Authors:  Lakshmi N Kurnutala; Suren Soghomonyan; Sergio D Bergese
Journal:  Front Pharmacol       Date:  2014-08-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.